Trial taking place at Sheikh Khalifa Medical City, a flagship United Arab Emirates hospital and largest teaching medical center in Abu Dhabi
Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both SBS-IF and MVID
Proof-of-concept (POC) data generated from this study could potentially lead to reimbursed early patient access in certain European countries for crofelemer for these rare/orphan diseases
Read More
The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in Telephone and Data Systems, Inc. (NYSE:TDS) shares. Investors who purchased shares of Telephone and Data Systems, Inc. (NYSE:TDS) prior to May 2022 and continue to hold any of those NYSE: TDS shares should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read More
As a VIP Sponsor of the Tampa Bay Tech Golf Classic, NIX supports the Apprenticeship Network, which combines on-the-job training and mentorship to prepare young talent for tech careers, raising funds for their growth.
Read More
The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in The Toronto-Dominion Bank (NYSE: TD) shares. Investors who purchased shares of The Toronto-Dominion Bank on the NYSE should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
Read MoreCerrado is building undervalued world class assets to drive significant cash flow
Attractive opportunity to acquire 80% of the robust Lagoa Salgada VMS Project with a Post-tax NPV of US$147 million and a 39% IRR in current Feasibility Study.
Adds substantial precious metals and critical minerals exposure (34% silver & Gold, 30% Zinc, 15% copper, 14% lead, 7% tin)
Expected lowest cost quartile production with US$0.59/lb Zinc Equivalent All in sustaining cost (AISC) for the first 5 years
Underexplored asset with extensive exploration potential
Optimized Feasibility Study due in Q3, construction decision by year end 2025 and initial production expected in second half of 2027.
Limited equity dilution required to bring Lagoa Salgada to production
Cerrado current Cash position of US$21 million budgeted to end year flat after all capital expenditures and debt reduction. Projected cash balance does not include payment of $15M due from asset sale to Hochschild and potential $10M option payment from Anglo Gold.
EIA Approval expected in Q2 2025 and Optimized Feasibility Study in Q3 2025
Construction well supported with low-cost Export Credit Agency Project Financing with Tier 1 lenders, support from Sprott and potential off takers to move the project into production.
Management to host Conference Call to discuss transaction on February 3, 2025, at 10:00 AM EST
Ranked #1 in EHR & Digital Health Solutions by Black Book Research surveys of nearly 28,000 global EHR users-Leading Innovation Across All Spanish-Speaking Latin American Countries, Germany, Austria, Switzerland, Liechtenstein (DACHL), Portugal, the UK, and Italy with AI, Cloud, and Interoperability.
Read More
New Black Book Research survey reveals industry-wide concerns as tariffs on imports from Mexico, Canada, and China threaten to escalate healthcare costs, disrupt supply chains, and create affordability challenges for patients.
Read More